Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer. [electronic resource]
Producer: 20020509Description: 129-35 p. digitalISSN:- 0090-8258
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- CA-125 Antigen -- blood
- Carboplatin -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Middle Aged
- Neoplasm Staging
- Ovarian Neoplasms -- blood
- Paclitaxel -- administration & dosage
- Topotecan -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.